CDCP1 and cancer: CAFs were considered to produce metabolic intermediates as a fuel source for cancer cells to favor PDAC progression.[49] CDCP1+FTL+ CAFs exhibited similar transcriptional profiles to previously characterized meCAFs,[50] both of which displayed a highly active glycolysis pathway.